UNIVERSAL HEALTH SERVICES INC
No SEC Form 4 filings for $UHS in the last 30 days.
Universal Health Services (UHS) reported Q2 revenue up 8.3% to $4.64B and net income attributable to UHS of $358.4M ($5.98/share). Despite growth, it cut the 2026 adjusted EPS and adjusted EBITDA outlook midpoints by 2.6% and 1.9%, citing changing Medicaid reimbursements and operating trends. It also reported first-half revenue up 8.9% to $9.13B.
Universal Health Services reported Q2 2026 revenue of $4.64B, up 8.3% year over year and slightly above estimates ($4.59B). Adjusted EPS was $5.98, near expectations, while adjusted EBITDA was $684M. Full-year adjusted EPS guidance midpoint was $22.97, below estimates, and EBITDA guidance midpoint was $2.66B. Management discussed acute care volume moderation, bed ramp-up, Talkspace integration, and Medicaid supplemental payment uncertainty.
Hospitals in the US report a rise in uninsured patients after enhanced ACA subsidies were not extended, according to The New York Times and Healthcare Dive. Universal Health Services (UHS) said losses from treating uninsured patients are higher than expected, and HCA Healthcare projected a $400 million revenue hit tied partly to more uninsured patients. SSM Health CEO cited patients unable to pay emergency bills.
Over the past 7 days, alphai's AI scored 2 news stories mentioning UHS (UNIVERSAL HEALTH SERVICES INC). Coverage has skewed bearish: 0 bullish, 1 neutral, and 1 bearish.
Recent UHS coverage spans financial news, earnings and sector analysis.
Guidance midpoint reductions despite revenue growth suggest margin/reimbursement uncertainty, likely pressuring near-term sentiment and valuation multiples.
The earnings call highlights a revenue beat but full-year EBITDA and EPS guidance that miss consensus, with volume growth moderated by care-setting shifts.
Higher-than-expected uninsured-patient losses can pressure near-term margins and raise sensitivity to further ACA subsidy changes.
Regulatory-jurisdiction dispute could delay the July 31 operational close and potentially force litigation, increasing deal execution risk for UHS.
Guidance reduction after an earnings beat likely shifts expectations toward slower FY2026 earnings growth, pressuring valuation multiples.
alphai scores every news story that mentions UHS with an AI model for sentiment and relevance, and aggregates insider trades from UNIVERSAL HEALTH SERVICES INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Universal Health Services (UHS) reported Q2 revenue up 8.3% to $4.64B and net income attributable to UHS of $358.4M ($5.98/share). Despite growth, it cut the 2026 adjusted EPS and adjusted EBITDA outlook midpoints by 2.6% and 1.9%, citing changing Medicaid reimbursements and operating trends. It also reported first-half revenue up 8.9% to $9.13B.
4 min readUniversal Health Services reported Q2 2026 revenue of $4.64B, up 8.3% year over year and slightly above estimates ($4.59B). Adjusted EPS was $5.98, near expectations, while adjusted EBITDA was $684M. Full-year adjusted EPS guidance midpoint was $22.97, below estimates, and EBITDA guidance midpoint was $2.66B. Management discussed acute care volume moderation, bed ramp-up, Talkspace integration, and Medicaid supplemental payment uncertainty.
6 min readHospitals in the US report a rise in uninsured patients after enhanced ACA subsidies were not extended, according to The New York Times and Healthcare Dive. Universal Health Services (UHS) said losses from treating uninsured patients are higher than expected, and HCA Healthcare projected a $400 million revenue hit tied partly to more uninsured patients. SSM Health CEO cited patients unable to pay emergency bills.
6 min readGeorge Washington University’s Medical Faculty Associates (MFA) faces a stalled takeover as a jurisdiction dispute delays regulatory review. MFA, treating 4,600+ patients daily with over $400 million debt, would be acquired by Universal Health Services (UHS), with most doctors becoming UHS employees. D.C. AG Brian Schwalb ordered submission of documents by Sept. 30; parties dispute his authority.
6 min readUniversal Health Services (UHS) reported Q2 EPS of $5.98, above the $5.96 consensus, and sales of $4.638B, above $4.577B. The company cut FY2026 adjusted EPS guidance to $22.28-$23.65 from $22.64-$24.52. UHS shares rose 0.6% to $167.14. Analysts at Baird and Guggenheim lowered price targets after the results.
2 min readUBS lowered its price target for Universal Health Services to $290 from $310 while keeping a Buy rating, according to the note cited in the article. The stock was shown trading around $168.32 at publication.
1 min readMorgan Stanley lowered its Universal Health Services price target to $191 from $212 and kept an Equal Weight rating, according to the firm. The article cites the stock’s recent performance but provides no new company fundamentals or earnings figures.
1 min readBaird lowered its price target for Universal Health Services to $166 from $204 and kept a Neutral rating, according to the firm. The stock was quoted around $168.26, up 1.23% on the day and down 22.67% year to date, per the article’s market data.
1 min readGuggenheim adjusted its price target for Universal Health Services to $189 from $195 and kept a Buy rating, according to the firm. The article cites the stock’s recent performance but provides no new company financial results.
1 min readLeerink Partners lowered its Universal Health Services (UHS) price target to $198 from $215 while keeping an Outperform rating, according to the firm. The note cites its composite methodology for valuation and EPS revisions, and maintains the stock’s relative rating for investors.
1 min read
